Sanofi's Strategic Share Buyback

In a significant move to reinforce its strategic priorities and partnerships, Sanofi S.A. has announced a major share buyback from L'Oreal S.A. This transaction, part of a broader share buyback program initiated on January 30, involves the repurchase of 2.3% of Sanofi's shares.

Transaction Details and Impact

Sanofi will acquire 29,556,650 shares at a price of €101.50 each, marking a 2.8% discount to the closing price on January 31, 2025. The total value of this deal stands at an impressive €3 billion. Post-transaction, L'Oreal's stake in Sanofi will adjust to 7.2%, with 13.1% of voting rights.

Strengthening a Long-standing Partnership

Francois Roger, Sanofi's Chief Financial Officer, emphasized the value of L'Oreal as a trusted shareholder and partner. "L'Oreal has been instrumental in supporting Sanofi’s growth and transformation. We are delighted to continue this partnership, which underscores our commitment to sustainable value creation and the strength of our strategic alliances," Roger stated.